These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 9542721

  • 1. Further pharmacological study on Sho-seiryu-to as an antiallergic.
    Sakaguchi M, Mase A, Iizuka A, Yuzurihara M, Ishige A, Amagaya S, Komatsu Y, Takeda H, Matsumiya T.
    Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):707-13. PubMed ID: 9542721
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological characteristics of Sho-seiryu-to, an antiallergic Kampo medicine without effects on histamine H1 receptors and muscarinic cholinergic system in the brain.
    Sakaguchi M, Iizuka A, Yuzurihara M, Ishige A, Komatsu Y, Matsumiya T, Takeda H.
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(1):41-7. PubMed ID: 8721255
    [Abstract] [Full Text] [Related]

  • 3. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J, Duval D, Prouteau M, Voltz C, Berry CN, Lloyd KG, Scatton B.
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [Abstract] [Full Text] [Related]

  • 4. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K, Kamei C, Akagi M, Mio M, Shirasaka T, Chokki M.
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [Abstract] [Full Text] [Related]

  • 5. Studies on the novel antiallergic agent HSR-609: its penetration into the central nervous system in mice and guinea pigs and its selectivity for the histamine H1-receptor.
    Kakiuchi M, Ohashi T, Musoh K, Kawamura K, Morikawa K, Kato H.
    Jpn J Pharmacol; 1997 Apr; 73(4):291-8. PubMed ID: 9165365
    [Abstract] [Full Text] [Related]

  • 6. In vivo antiinfluenza virus activity of Kampo medicine Sho-seiryu-to through mucosal immune system.
    Yamada H, Nagai T.
    Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):185-92. PubMed ID: 9646280
    [Abstract] [Full Text] [Related]

  • 7. Sho-seiryu-to suppresses histamine signaling at the transcriptional level in TDI-sensitized nasal allergy model rats.
    Das AK, Mizuguchi H, Kodama M, Dev S, Umehara H, Kitamura Y, Matsushita C, Takeda N, Fukui H.
    Allergol Int; 2009 Mar; 58(1):81-8. PubMed ID: 19050374
    [Abstract] [Full Text] [Related]

  • 8. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, García-Rafanell J, Forn J.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of immunological histamine release from guinea pig lungs and other organs by mepyramine, ketotifen, and picumast in vivo.
    Sekardi L, Friedberg KD.
    Arzneimittelforschung; 1989 Oct; 39(10A):1331-5. PubMed ID: 2483312
    [Abstract] [Full Text] [Related]

  • 10. [The effect of antihistaminic preparations on the binding of labelled mepyramine, ketanserin and quinuclidinyl benzilate in the rat brain].
    Gankina EM, Porodenko NV, Kondratenko TI, Severin ES, Kaminka ME, Mashkovskiĭ MD.
    Eksp Klin Farmakol; 1993 Oct; 56(1):22-4. PubMed ID: 8100727
    [Abstract] [Full Text] [Related]

  • 11. Dissociation between central and peripheral antihistamine activities of the new antiallergic agent N-[4-[4-(diphenylmethyl)-1-piperazinyl]-butyl]-3-(6-methyl-3-pyridyl) acrylamide in rats and monkeys.
    Ishii K, Yakuo I, Nakagawa H, Nakamura H.
    Arzneimittelforschung; 1993 Jun; 43(6):668-71. PubMed ID: 8102529
    [Abstract] [Full Text] [Related]

  • 12. Effects of Sho-seiryu-to on experimental allergic rhinitis in guinea pigs.
    Sakaguchi M, Mase A, Ikeda Y, Iizuka A, Imamura S, Komatsu Y, Ukai K, Sakakura Y.
    Methods Find Exp Clin Pharmacol; 1999 May; 21(4):303-8. PubMed ID: 10399140
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative.
    Fukuda S, Midoro K, Yamasaki M, Gyoten M, Kawano Y, Fukui H, Ashida Y, Nagaya H.
    Inflamm Res; 2003 May; 52(5):206-14. PubMed ID: 12813625
    [Abstract] [Full Text] [Related]

  • 14. Pharmacology of [3H]-pyrilamine binding and of the histamine-induced inositol phosphates generation, intracellular Ca2+ -mobilization and cytokine release from human corneal epithelial cells.
    Sharif NA, Wiernas TK, Griffin BW, Davis TL.
    Br J Pharmacol; 1998 Nov; 125(6):1336-44. PubMed ID: 9863665
    [Abstract] [Full Text] [Related]

  • 15. Effect of loratadine on immediate and delayed type hypersensitivity reactions.
    Tasaka K, Kamei C, Akagi M, Mio M, Izushi K, Yoshida T, Nakamura S.
    Arzneimittelforschung; 1995 Jul; 45(7):796-804. PubMed ID: 8573225
    [Abstract] [Full Text] [Related]

  • 16. Preclinical comparison of ebastine and other second generation H1-antihistamines.
    Yakuo I, Yabuuchi M, Ito T.
    Pharmacol Toxicol; 2001 Oct; 89(4):171-6. PubMed ID: 11881966
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of non-drowsiness after oral administration of TMK688, a novel antiallergic drug.
    Shizawa T, Inaba K, Yoshida F, Iizuka T, Hijikuro K, Yanoshita R, Kamitani T.
    Arzneimittelforschung; 1998 Oct; 48(10):979-84. PubMed ID: 9825114
    [Abstract] [Full Text] [Related]

  • 18. Relationship between occupation of cerebral H1-receptors and sedative properties of antihistamines. Assessment in the case of terfenadine.
    Rose C, Quach TT, Llorens C, Schwartz JC.
    Arzneimittelforschung; 1982 Oct; 32(9a):1171-3. PubMed ID: 6129863
    [Abstract] [Full Text] [Related]

  • 19. Does the [3H]mepyramine binding site represent the histamine H1 receptor? Re-examination of the histamine H1 receptor with quinine.
    Liu Q, Horio Y, Fujimoto K, Fukui H.
    J Pharmacol Exp Ther; 1994 Feb; 268(2):959-64. PubMed ID: 8114011
    [Abstract] [Full Text] [Related]

  • 20. The ex vivo effect of the herbal medicine sho-saiko-to on histamine release from rat mast cells.
    Matsumoto T, Shibata T.
    Eur Arch Otorhinolaryngol; 1998 Feb; 255(7):359-64. PubMed ID: 9783133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.